Open AccessGlecaprevir and pibrentasvir for 12 weeks for hepatitis C virus genotype 1 infection and prior direct-acting antiviral treatment: Poordad et al.
Author(s) -
Fred Poordad,
Franco Felizarta,
Armen Asatryan,
Mark S. Sulkowski,
Robert Reindollar,
Charles Landis,
Stuart C. Gordon,
Steven L. Flamm,
Michael Fried,
David Bernstein,
ChihWei Lin,
Ran Liu,
Sandra Lovell,
Teresa I. Ng,
Jens Kort,
Federico Mensa
Publication year - 2017
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/tf1e-zm69
Subject(s) - genotype , virology , hepatitis c virus , medicine , virus , biology , gene , genetics